Artículos Científicos en Ingles

Treatment of IgA Nephropathy: A Rapidly Evolving Field ...	Initial Management and Potential Opportunities to Deprescribe Dialysis among Patients with AKI-D Patients after Hospital Discharge ...	Uncovering Rare Coding Variants in IgA Nephropathy ...
Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure ...

Early therapy with sirolimus reduces size of a large solid renal mass but not seizure activity in an infant with tuberous sclerosis Este artículo no posee resumen	General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis Abstract ...	A myoglobin cast-astrophe: a case of severe rhabdomyolysis with AKI secondary to carbimazole use Este artículo no posee resumen
Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions Abstract ...

Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis Atrial fibrillation (AF) and chronic kidney disease (CKD...	Automated Urinary Chemokine Assays for Non-Invasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study Prior studies have demonstrated the diagnostic potential...	Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis Atrial fibrillation (AF) and chronic kidney disease (CKD...
Disparities in Gender Representation Among First and Senior Authors in High-Impact Nephrology RCTs, 2000-2022 Growing awareness of diversity and inclusivity in the...	Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series Rituximab is the first-choice therapy for patients with...	Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study Prior studies have demonstrated the diagnostic potential...
Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy Rituximab is the first-choice therapy for patients with...

Menú de usuario